[Modeling parkinsonism (review)].
D000535:Aluminum; D000818:Animals; D002217:Carbachol; D002415:Cats; D002421:Caudate Nucleus / Q000503:physiopathology; D002712:Chlorides; D002746:Chlorpromazine; D004195:Disease Models, Animal; D005917:Globus Pallidus / Q000473:pathology; D006801:Humans; D006892:Hydroxydopamines; D008345:Manganese; D017895:Manganese Compounds; D016627:Oxidopamine; D010300:Parkinson Disease / Q000209:etiology; D010302:Parkinson Disease, Secondary / Q000139:chemically induced; D011699:Putamen / Q000473:pathology; D011817:Rabbits; D051381:Rats; D012012:Red Nucleus / Q000473:pathology; D012110:Reserpine; D013378:Substantia Nigra / Q000473:pathology; D013577:Syndrome; D013744:Tetanus Toxin; D013788:Thalamus / Q000503:physiopathology; D014414:Tungsten; D017973:Tungsten Compounds
D002712:Chlorides; D006892:Hydroxydopamines; D017895:Manganese Compounds; D013744:Tetanus Toxin; D017973:Tungsten Compounds; D008345:Manganese; D012110:Reserpine; D016627:Oxidopamine; D002217:Carbachol; D000535:Aluminum; C021101:tungstic(VI) acid; C025340:manganese chloride; D002746:Chlorpromazine; D014414:Tungsten
Modelirovanie parkinsonizma (obzor).